-- テリックス・ファーマシューティカルズ(ASX:TLX)は金曜日、同社の神経膠腫画像診断薬候補TLX101-Pxの欧州における販売承認申請が受理され、210日間の積極的評価段階に入ったと発表した。 同社は声明の中で、現在の臨床診療ガイドラインを反映した幅広い臨床適応症を目指しており、210日目の審査で良好な結果が得られれば、間もなく各国での販売承認が得られる見込みだと述べた。 同社は、成人および小児において、進行性または再発性の神経膠腫と治療関連の変化を区別できる高度な画像診断への患者アクセスを拡大することを目指しており、将来的には追加の適応症の可能性もあるとしている。 声明によると、TLX101-Pxは、テリックス社の膠芽腫治療薬候補TLX101-Txの患者選択および治療効果判定ツールとしても開発されており、TLX101-Txは欧州および米国で希少疾病用医薬品指定を受けている。 再発性膠芽腫患者を対象としたTLX101-Txの第3相IPAX-BrIGHT試験が国際的に開始され、複数の欧州諸国で試験が開始される予定であると、同社は発表した。 テリックス・ファーマシューティカルズの株価は、直近の金曜日の取引で3%上昇した。
Related Articles
Australia's Producer Prices Rise in March Quarter
Australia's producer prices, excluding exports, increased 0.4% in the March quarter, following a 0.8% rise in the December 2025 quarter, according to data from the Australian Bureau of Statistics published Friday.The main drivers of quarterly growth were property operators, up 1% amid strong demand and rising residential rents; petroleum refining and petroleum fuel manufacturing, up over 10% due to higher oil prices; and tertiary education services, which rose 2.2% due to annual fee adjustments, the report said.Selected producer price indexes rose across key sectors, including a 2.1% increase in manufacturing driven by non-ferrous metals, a 1% rise in construction driven by house building, and an increase in education and training services due to higher export fees in higher education.On an annual basis, final demand growth rose 3% in the year to the March quarter, down from a 3.7% increase a year earlier.
Tokyo Inflation Hits Four-Year Low as Oil, Yen Cloud Outlook
Tokyo inflation lost momentum again, underscoring the Bank of Japan's dilemma as price pressures build unevenly. Core consumer prices in the capital rose 1.5% in April, the slowest pace in four years and below the central bank's 2% target for a third straight month.The reading marked a fifth consecutive slowdown and came in under market expectations. A narrower gauge that strips out both fresh food and energy, which is also closely watched by policymakers, increased 1.9%, also easing from the prior month.The softer print partly reflects government fuel subsidies and one-off factors such as a sharp drop in nursery school fees, alongside moderating gains in durable goods and processed food. Energy prices continued to decline, though at a slower pace.Still, the calm may not last. Rising oil prices tied to the Middle East conflict and a weaker yen are expected to push up import costs in the months ahead.The outlook is already complicating policy decisions.The BOJ kept rates unchanged this week in a split decision, even as some officials leaned toward tightening. Governor Kazuo Ueda signaled flexibility, leaving room to wait as risks to growth intensify.Currency moves add another layer. Authorities stepped into the foreign exchange market to support the yen after it slid near 160 per dollar, highlighting concern that prolonged weakness could further inflate import bills."We expect the BOJ to guard against an inflation overshoot. That strengthens the case for a 25-basis-point hike in June, but the latest reading suggests it's far from certain," said Bloomberg economist Taro Kimura."The central bank is also watching uncertainty around the Iran war and the government's willingness to support growth amid a crude oil squeeze."
Sony Financial Unit Ordered to Submit Reports Tied to Misconduct Handling, Customer Policy Review
Sony Financial (TYO:8729) said its unit, Sony Life Insurance, received an order from the Financial Services Agency to submit reports under the Insurance Business Act, according to a delayed Friday filing on the Tokyo Stock Exchange.The order relates to the insurer's handling of misconduct cases and an ongoing review of customer policy status. Sony Financial said the impact on its consolidated earnings is unclear.Sony Life said it takes the order seriously and will work to strengthen controls, prevent misconduct and improve oversight of customer policies. It plans to report progress on its internal review by the end of May.